(Q40359055)

19 September 2017

title

Clostridium difficile infection at a medical center in southern Taiwan: incidence, clinical features and prognosis (English)

1 reference

19 September 2017

main subject

Clostridium difficile

0 references

author name string

Chih-Huan Chung

1

1 reference

19 September 2017

Chi-Jung Wu

2

1 reference

19 September 2017

Hsin-Chun Lee

3

1 reference

19 September 2017

Jing-Jou Yan

4

1 reference

19 September 2017

Chia-Ming Chang

5

1 reference

19 September 2017

Nan-Yao Lee

6

1 reference

19 September 2017

Po-Lin Chen

7

1 reference

19 September 2017

Ching-Chi Lee

8

1 reference

19 September 2017

Yuan-Pin Hung

9

1 reference

19 September 2017

Wen-Chien Ko

10

1 reference

19 September 2017

publication date

1 April 2010

1 reference

Journal of Microbiology Immunology and Infection

19 September 2017

published in

1 reference

19 September 2017

volume

43

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

119-125

1 reference

INTESTINAL FLORA IN NEW-BORN INFANTS

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

An update on diagnosis, treatment, and prevention of Clostridium difficile-associated disease

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

Clostridium difficile-associated disease in Oregon: increasing incidence and hospital-level risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

Recommendations for surveillance of Clostridium difficile-associated disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

Epidemiology of Clostridium difficile infection in a large teaching hospital in Singapore

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

Is diarrhea enough to assess the severity of Clostridium difficile-associated disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

Clostridium difficile infection in patients with unexplained leukocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

Is Fecal Leukocyte Test a good predictor of Clostridium difficile associated diarrhea?

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

Antibiotic-induced diarrhea: specificity of abdominal CT for the diagnosis of Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

Colonic abnormalities on CT in adult hospitalized patients with Clostridium difficile colitis: prevalence and significance of findings.

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

Risk factors for Clostridium difficile toxin-positive nosocomial diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS1684-1182%2810%2960019-9

7 January 2021

10.1016/S1684-1182(10)60019-9

Identifiers

DOI

1 reference

19 September 2017

1 reference